MarketInOut Stock Screener Log In | Sign Up

Broncus Holding Corp

HKSE • Healthcare • Medical Devices • Quote as of 10/30/2026
Broncus Holding Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeHKSE
Market Capitalization289.89 mln
Float454 mln
Earnings Date03/31/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

9.37
Highly suspicious

Relative Strength

47 / 100
In line with market

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-247%
Severely loss-making

ROE

-5.35
Negative

Business Description

Broncus Holding Corporation, founded in 2012 and headquartered in Hangzhou, China, develops and sells medical devices for treating lung conditions both in China and worldwide. Its product range covers tools for managing COPD, diagnosing and treating lung cancer, guiding lung biopsies, and delivering targeted airway therapies. The company also offers software-based navigation systems that help physicians perform precise bronchoscopic procedures.

Key Fundamentals

EPS-0.31
ROE-5.35
RPS0.03
ROIC-26.31
ROA-5.13
Interest Cover-3,018
EBITDA, mln-57.64
EV / EBITDA7.16
EV / EBIT6.49
Revenue, mln25.73

Quote Details

Last 0.58
Change 0.045 (8.41%)
Open 0.535
Volume 394,000
Turnover 228,520
Average Volume 324,651

Financial Ratios

Pre-Tax Profit Margin-247
Leverage Ratio1.05
Current Ratio15.43
Price / Book0.34
Price / Tangible Book0.36
Debt / Equity0.00
Price / Sales13.87

Financial Strength

Altman Z-Score0.9
Piotroski F-Score 3 / 9
Beneish M-Score9.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.45% 88 / 100   
1 Month -24.18% 12 / 100   
2 Months -12.12% 44 / 100   
6 Months -50% 13 / 100   
1 Year -79.58% 3 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog